GlaxoSmithKline Pharma Q3 net up 69 pc at Rs 89 cr

Image
Press Trust of India New Delhi
Last Updated : Feb 02 2018 | 6:40 PM IST
Drug firm GlaxoSmithKline Pharmaceuticals today reported a 69.38 per cent rise in its standalone net profit to Rs 89.69 crore for the quarter ended December 2017.
The company had posted a net profit of Rs 52.95 crore for the same period of the previous fiscal, GlaxoSmithKline Pharmaceuticals said in a BSE filing.
Standalone revenue from operations of the company stood at Rs 703.91 crore for the quarter under consideration as against Rs 706.38 crore for the same period a year ago.
"Overall underlying performance, excluding the impacts of GST and prior year disposals, is supported by high single to double-digit volume growth on our key brands and therapy areas," GlaxoSmithKline Pharmaceuticals MD A Vaidheesh said.
During the quarter, the company has received the money in advance towards disposal of Thane Land, he added.
Shares of GlaxoSmithKline Pharmaceuticals today closed at Rs 2,439.25 per scrip on BSE, down 0.41 per cent from its previous close.

Disclaimer: No Business Standard Journalist was involved in creation of this content

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

First Published: Feb 02 2018 | 6:40 PM IST

Next Story